Clinical Trials Logo

Retinoblastoma, Recurrent clinical trials

View clinical trials related to Retinoblastoma, Recurrent.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03284268 Active, not recruiting - Clinical trials for Retinoblastoma, Recurrent

Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma

RTB
Start date: September 6, 2017
Phase: N/A
Study type: Interventional

Phase I study, single site, open label with dose escalation, for evaluate safety and the oncolitic Adenovirus VCN-01 activity in patients with refractory retinoblastoma.